PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
30.49%
Revenue growth above 1.5x RUN's 7.97%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
15.26%
Positive gross profit growth while RUN is negative. John Neff would see a clear operational edge over the competitor.
231.50%
Positive EBIT growth while RUN is negative. John Neff might see a substantial edge in operational management.
233.84%
Positive operating income growth while RUN is negative. John Neff might view this as a competitive edge in operations.
127.15%
Net income growth above 1.5x RUN's 11.71%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
118.18%
EPS growth above 1.5x RUN's 13.64%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
122.22%
Diluted EPS growth above 1.5x RUN's 13.64%. David Dodd would see if there's a robust moat protecting these shareholder gains.
1.12%
Share change of 1.12% while RUN is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
6.90%
Diluted share change of 6.90% while RUN is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
75.45%
Positive OCF growth while RUN is negative. John Neff would see this as a clear operational advantage vs. the competitor.
52.35%
Positive FCF growth while RUN is negative. John Neff would see a strong competitive edge in net cash generation.
No Data
No Data available this quarter, please select a different quarter.
2.55%
5Y CAGR of 2.55% while RUN is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
-29.64%
Negative 3Y CAGR while RUN stands at 0.00%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
-129.65%
Negative 5Y OCF/share CAGR while RUN is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-212.65%
Negative 3Y OCF/share CAGR while RUN stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
No Data
No Data available this quarter, please select a different quarter.
18.49%
Net income/share CAGR of 18.49% while RUN is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
106.47%
3Y net income/share CAGR of 106.47% while RUN is zero. Bruce Berkowitz sees if minor improvements can widen to a bigger advantage.
No Data
No Data available this quarter, please select a different quarter.
-26.07%
Negative 5Y equity/share growth while RUN is at 0.00%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-11.49%
Negative 3Y equity/share growth while RUN is at 0.00%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
14.73%
AR growth of 14.73% while RUN is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
-14.97%
Inventory is declining while RUN stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
2.00%
Asset growth of 2.00% while RUN is zero. Bruce Berkowitz checks if modest expansions can create a longer-term lead.
2.08%
BV/share growth of 2.08% while RUN is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
0.25%
Debt growth of 0.25% while RUN is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
4.28%
R&D growth drastically higher vs. RUN's 1.85%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-4.34%
We cut SG&A while RUN invests at 10.58%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.